Currently, Carisma Therapeutics Inc’s (CARM) stock is trading at $0.46, marking a fall of -8.86% from last night’s close. At this price, the stock is -83.39% below its 52-week high of $2.77 and 21.05% above its 52-week low of $0.38. Based on the past 30-day period, the stock price is -24.89% below the high and +16.02% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CARM’s SMA-200 is $1.0272.
As well, it is important to consider CARM stock ratios such as price-to-sales, which is currently 0.95.
How does Carisma Therapeutics Inc (CARM) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 6 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.67 in simple terms.
Carisma Therapeutics Inc (CARM): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 1 different analysts, who are expecting earnings to fall in between the range of -0.28 and -0.28 with an average Earnings Estimate of -0.28 which is in contrast with the last year earnings estimate of -0.52 and also replicates 46.15% growth rate year over year.
Carisma Therapeutics Inc (NASDAQ: CARM) Ownership Details
I will give a breakdown of the key shareholders in Carisma Therapeutics Inc (CARM). Recent figures show that the company’s insiders hold 27.40% of shares. A total of 50 institutional investors hold shares in the company, making 31.45% of its stock and 43.33% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Vanguard Group Inc holding total of 1.45 shares that make 3.47% of the company’s total number of shares and are currently priced at 0.68 million.
The securities firm Trustees of the University of Pennsylvania holds 1.25 shares of CARM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 3.00%, and the holding percentage of shares is valued at 0.59 million.
An overview of Carisma Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Carisma Therapeutics Inc (CARM) traded 510,894 shares per day, with a moving average of $0.4716 and price change of +0.0230. With the moving average of $0.5867 and a price change of -0.4748, about 399,702 shares changed hands on average over the past 50 days. Finally, CARM’s 100-day average volume is 275,461 shares, alongside a moving average of $0.7862 and a price change of -0.5324.
